US Stock MarketDetailed Quotes

IKNA Ikena Oncology

Watchlist
  • 1.410
  • -0.030-2.08%
Close Mar 10 16:00 ET
68.04MMarket Cap-1.38P/E (TTM)

Ikena Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
42.31%-46M
71.31%-6.26M
55.30%-8.94M
31.09%-12.5M
7.48%-18.3M
-7.60%-79.74M
-23.59%-21.82M
-16.13%-20M
6.72%-18.14M
0.00%-19.78M
Net income from continuing operations
27.77%-49.23M
53.18%-9.12M
40.99%-10.23M
19.78%-13.73M
-13.55%-16.15M
0.87%-68.17M
-38.25%-19.49M
-0.03%-17.34M
16.48%-17.12M
15.56%-14.22M
Operating gains losses
1,880.00%99K
--0
--0
--0
--99K
-97.30%5K
--0
--0
----
----
Depreciation and amortization
-51.96%490K
-70.82%89K
-62.81%90K
-61.98%92K
-5.19%219K
35.82%1.02M
45.24%305K
13.62%242K
63.51%242K
28.33%231K
Other non cash items
19.66%2.05M
-6.58%525K
31.42%619K
34.30%462K
32.05%445K
33.59%1.71M
70.30%562K
44.92%471K
8.86%344K
8.01%337K
Change In working capital
81.64%-3.98M
124.08%1.54M
98.66%-64K
93.75%-181K
30.67%-5.27M
-43.14%-21.67M
-8.10%-6.38M
-110.37%-4.79M
-83.41%-2.9M
-41.35%-7.6M
-Change in receivables
59.27%-1.17M
65.85%-643K
119.82%132K
49.24%-501K
-123.57%-157K
-886.25%-2.87M
-2,115.29%-1.88M
42.49%-666K
-204.11%-987K
16,550.00%666K
-Change in prepaid assets
25,172.73%2.78M
186.28%717K
-119.56%-194K
673.80%2.63M
-220.45%-371K
106.59%11K
-249.73%-831K
-52.92%992K
82.78%-458K
282.25%308K
-Change in payables and accrued expense
67.57%-2.48M
198.64%2.32M
120.75%684K
-289.87%-1.72M
-28.95%-3.76M
-443.50%-7.66M
-301.37%-2.35M
-193.96%-3.3M
9.40%908K
-91.66%-2.92M
-Change in other current liabilities
-56.08%-3.11M
-30.44%-857K
-8.54%-686K
-64.04%-584K
-183.77%-979K
-54.02%-1.99M
-94.38%-657K
-90.94%-632K
-12.66%-356K
-12.38%-345K
-Change in other working capital
----
----
----
----
----
41.35%-9.16M
87.91%-659K
81.49%-1.19M
-425.72%-2M
-57.00%-5.31M
Cash from discontinued investing activities
Operating cash flow
42.31%-46M
71.31%-6.26M
55.30%-8.94M
31.09%-12.5M
7.48%-18.3M
-7.60%-79.74M
-23.59%-21.82M
-16.13%-20M
6.72%-18.14M
0.00%-19.78M
Investing cash flow
Cash flow from continuing investing activities
-154.41%-34.9M
-97.73%463K
-70.36%9.45M
-82.72%3.92M
-351.03%-48.74M
164.61%64.14M
94.08%20.38M
-10.87%31.89M
10.71%22.68M
93.49%-10.81M
Net PPE purchase and sale
205.07%435K
--0
--190K
4,525.00%185K
139.47%60K
71.07%-414K
-15.15%-266K
--0
111.11%4K
-360.61%-152K
Net investment purchase and sale
-143.12%-27.84M
-61.42%7.96M
-70.95%9.26M
-83.54%3.73M
-358.03%-48.8M
165.97%64.56M
92.38%20.64M
-13.60%31.89M
10.50%22.68M
93.58%-10.65M
Net other investing changes
---7.5M
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-154.41%-34.9M
-97.73%463K
-70.36%9.45M
-82.72%3.92M
-351.03%-48.74M
164.61%64.14M
94.08%20.38M
-10.87%31.89M
10.71%22.68M
93.49%-10.81M
Financing cash flow
Cash flow from continuing financing activities
0
0
0
6,838.81%75.98M
5,900.00%60K
162,058.33%38.92M
Net common stock issuance
--0
--0
--0
----
----
--36.76M
--0
---123K
----
----
Net preferred stock issuance
--0
----
----
----
----
--40.03M
----
----
----
----
Proceeds from stock option exercised by employees
--0
--0
--0
----
----
-87.58%136K
--0
-37.50%15K
----
----
Net other financing activities
----
----
----
----
----
---944K
---39.97M
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
----
----
6,838.81%75.98M
5,900.00%60K
162,058.33%38.92M
----
----
Net cash flow
Beginning cash position
99.33%121.17M
-62.42%46.06M
-36.51%45.55M
79.23%54.13M
99.33%121.17M
-73.92%60.79M
80.37%122.56M
45.34%71.74M
-36.75%30.2M
-73.92%60.79M
Current changes in cash
-233.99%-80.91M
-319.16%-5.8M
-98.98%516K
-120.66%-8.58M
-119.16%-67.04M
135.04%60.38M
80.67%-1.38M
173.39%50.82M
2,480.06%41.54M
83.50%-30.59M
End cash Position
-66.77%40.27M
-66.77%40.27M
-62.42%46.06M
-36.51%45.55M
79.23%54.13M
99.33%121.17M
99.33%121.17M
80.37%122.56M
45.34%71.74M
-36.75%30.2M
Free cash flow
42.61%-46M
71.65%-6.26M
55.30%-8.94M
31.09%-12.5M
8.19%-18.3M
-6.11%-80.16M
-23.45%-22.08M
-8.98%-20M
6.90%-18.14M
-0.60%-19.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 42.31%-46M71.31%-6.26M55.30%-8.94M31.09%-12.5M7.48%-18.3M-7.60%-79.74M-23.59%-21.82M-16.13%-20M6.72%-18.14M0.00%-19.78M
Net income from continuing operations 27.77%-49.23M53.18%-9.12M40.99%-10.23M19.78%-13.73M-13.55%-16.15M0.87%-68.17M-38.25%-19.49M-0.03%-17.34M16.48%-17.12M15.56%-14.22M
Operating gains losses 1,880.00%99K--0--0--0--99K-97.30%5K--0--0--------
Depreciation and amortization -51.96%490K-70.82%89K-62.81%90K-61.98%92K-5.19%219K35.82%1.02M45.24%305K13.62%242K63.51%242K28.33%231K
Other non cash items 19.66%2.05M-6.58%525K31.42%619K34.30%462K32.05%445K33.59%1.71M70.30%562K44.92%471K8.86%344K8.01%337K
Change In working capital 81.64%-3.98M124.08%1.54M98.66%-64K93.75%-181K30.67%-5.27M-43.14%-21.67M-8.10%-6.38M-110.37%-4.79M-83.41%-2.9M-41.35%-7.6M
-Change in receivables 59.27%-1.17M65.85%-643K119.82%132K49.24%-501K-123.57%-157K-886.25%-2.87M-2,115.29%-1.88M42.49%-666K-204.11%-987K16,550.00%666K
-Change in prepaid assets 25,172.73%2.78M186.28%717K-119.56%-194K673.80%2.63M-220.45%-371K106.59%11K-249.73%-831K-52.92%992K82.78%-458K282.25%308K
-Change in payables and accrued expense 67.57%-2.48M198.64%2.32M120.75%684K-289.87%-1.72M-28.95%-3.76M-443.50%-7.66M-301.37%-2.35M-193.96%-3.3M9.40%908K-91.66%-2.92M
-Change in other current liabilities -56.08%-3.11M-30.44%-857K-8.54%-686K-64.04%-584K-183.77%-979K-54.02%-1.99M-94.38%-657K-90.94%-632K-12.66%-356K-12.38%-345K
-Change in other working capital --------------------41.35%-9.16M87.91%-659K81.49%-1.19M-425.72%-2M-57.00%-5.31M
Cash from discontinued investing activities
Operating cash flow 42.31%-46M71.31%-6.26M55.30%-8.94M31.09%-12.5M7.48%-18.3M-7.60%-79.74M-23.59%-21.82M-16.13%-20M6.72%-18.14M0.00%-19.78M
Investing cash flow
Cash flow from continuing investing activities -154.41%-34.9M-97.73%463K-70.36%9.45M-82.72%3.92M-351.03%-48.74M164.61%64.14M94.08%20.38M-10.87%31.89M10.71%22.68M93.49%-10.81M
Net PPE purchase and sale 205.07%435K--0--190K4,525.00%185K139.47%60K71.07%-414K-15.15%-266K--0111.11%4K-360.61%-152K
Net investment purchase and sale -143.12%-27.84M-61.42%7.96M-70.95%9.26M-83.54%3.73M-358.03%-48.8M165.97%64.56M92.38%20.64M-13.60%31.89M10.50%22.68M93.58%-10.65M
Net other investing changes ---7.5M------------------------------------
Cash from discontinued investing activities
Investing cash flow -154.41%-34.9M-97.73%463K-70.36%9.45M-82.72%3.92M-351.03%-48.74M164.61%64.14M94.08%20.38M-10.87%31.89M10.71%22.68M93.49%-10.81M
Financing cash flow
Cash flow from continuing financing activities 0006,838.81%75.98M5,900.00%60K162,058.33%38.92M
Net common stock issuance --0--0--0----------36.76M--0---123K--------
Net preferred stock issuance --0------------------40.03M----------------
Proceeds from stock option exercised by employees --0--0--0---------87.58%136K--0-37.50%15K--------
Net other financing activities -----------------------944K---39.97M------------
Cash from discontinued financing activities
Financing cash flow --0--0--0--------6,838.81%75.98M5,900.00%60K162,058.33%38.92M--------
Net cash flow
Beginning cash position 99.33%121.17M-62.42%46.06M-36.51%45.55M79.23%54.13M99.33%121.17M-73.92%60.79M80.37%122.56M45.34%71.74M-36.75%30.2M-73.92%60.79M
Current changes in cash -233.99%-80.91M-319.16%-5.8M-98.98%516K-120.66%-8.58M-119.16%-67.04M135.04%60.38M80.67%-1.38M173.39%50.82M2,480.06%41.54M83.50%-30.59M
End cash Position -66.77%40.27M-66.77%40.27M-62.42%46.06M-36.51%45.55M79.23%54.13M99.33%121.17M99.33%121.17M80.37%122.56M45.34%71.74M-36.75%30.2M
Free cash flow 42.61%-46M71.65%-6.26M55.30%-8.94M31.09%-12.5M8.19%-18.3M-6.11%-80.16M-23.45%-22.08M-8.98%-20M6.90%-18.14M-0.60%-19.94M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
D.R. Horton
DHI
+0.40%
Lennar Corp
LEN
+0.02%
KB Home
KBH
-0.06%
Petroleo Brasileiro SA Petrobras
PBR
-1.46%
Ecopetrol
EC
-1.81%

Unlock the Full List